Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

GenSight Biologics S.A.. (11/20/23). "Press Release: GenSight Biologics Announces Launch of an Offering for an Indicative Amount of €5 Million that Has Received Subscription Commitments from New and Existing Shareholders Totaling €4 Million". Paris.

Organisations Organisation GenSight Biologics S.A. (Euronext: SIGHT)
  Organisation 2 Invus Group (Group)
Products Product gene therapy eye disease
  Product 2 investment banking
Person Person Moreau, Cédric (Sofinnova 202103 Partner at Sofinnova Crossover Fund)
     


   
Record changed: 2024-01-20

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for GenSight Biologics S.A. (Euronext: SIGHT)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top